Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians.
Where this comes from
- Record sourced from PubMed, PMID 31282918.
- Also identified by DOI 10.1001/jamainternmed.2019.0999 and PMC identifier 6618793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This economic evaluation examines whether pharmaceutical industry payments to gastroenterologists are associated with how often they prescribe the pharmaceuticals’ drugs for inflammatory bowel disease.